Table 1.
Articles of RCTs studies of interventions for patients with multimorbidity in primary care settings included in the review.
| References | Country | Control group | Intervention group | Methods | Results of primary outcomes | |||
|---|---|---|---|---|---|---|---|---|
| Number of patients | Mean age, y | Number of patients | Mean age, y | Intervention | Primary outcomes† | |||
| Main article: Fortin et al. (7)Related article:Ngangue et al. (8) | Canada | 140 | 61.1 | 144 | 60.8 | Pragmatic randomized controlled trial | heiQ SE-CD |
Neutral |
| Main article:Stewart et al. (9)Related article:Pariser et al. (10) | Canada | 77 | 63.1 | 86 | 61.9 | Pragmatic randomized controlled trial | heiQ SE-CD |
Neutral |
| Main article:Salisbury et al. (6)Related article:Salisbury et al. (11) | UK | 749 | 70.7 | 797 | 71.0 | Pragmatic randomized controlled trial | EQ-5D-5L | Neutral |
| O'Toole et al. (12) | Ireland | 71 | 65.9 | 78 | 65.5 | Pragmatic randomized controlled trial | EQ-5D-3L EQ-VAS |
Improvement in EQ-VAS in those aged <65 years |
| Kari et al. (13) | Finland | 126 | 81.4 | 151 | 81.0 | Randomized controlled trial | SF-36 | Neutral |
| Verdoorn et al. (14) | Netherlands | 314 | 78* | 315 | 80* | Pragmatic randomized controlled trial | EQ-5D-5L EQ-VAS No. health problems |
Improvement in EQ-VAS and No. health problems |
*
Median age.
†
heiQ, Health Education Impact Questionnaire; SE-CD, Self-Efficacy for Managing Chronic Diseases; EQ-5D, EuroQol-5Dimensions; EQ-VAS, EuroQol Visual Analog Scale; SF-36, 36-Item Short-Form Health Survey.